Overall, this work proves that BSJPD can prolong the survival of patients with LC and promote hepatoma cell apoptosis, which is connected to its modulation of the PI3K-Akt-mTOR pathway and the p53, CASP3, and Bcl-xL/BAD proteins. This evidence concerns the gene BCL2L1 and hepatocellular carcinoma.